Men with prostate cancer are being given false hope by tests that underestimate the aggressiveness of their disease, a study suggests.
Researchers found that more than half of a group of men whose cancers were initially classified as slow-growing and confined turned out to have more dangerous tumours.
The findings, published in the British Journal Of Cancer, call into question the ability of experts to grade and stage prostate cancers on the basis of biopsy samples.
It also casts doubt on the "active surveillance" strategy of avoiding unnecessary radical treatment for patients with slow-growing prostate cancer.
Instead, these patients are often closely monitored but left alone until tests suggest their condition has worsened.
More top news
Armies of protesters took to the streets following the Ferguson shooting decision, in a sign of the monumental challenge now facing America.
Half the UK's pre-pay gas meters are suspected of overcharging by an average of £7 a year, ITV News understands...so what has gone wrong?
Dr Steve Hewitt, from the University of Birmingham, says there isn't much more the government can do to tackle terrorism.